Full article view 2018-01-30T13:39:05+00:00
Back to News & Insights »

Schafer, Galante, and Shafrin in JMCP: New Precision Survey Provides Insight Into Payer Use of Value Tools

 

In the current supplemental issue of Journal of Managed Care & Specialty Pharmacy (JMCP), Precision’s Jeremy Schafer, Dominic Galante, and Jason Shafrin share results of a recent survey of payers discerning payers’ use of value tools in healthcare decision-making.

Deploying Precision for Value’s Rapid Pulse survey tool to 28 payer respondents—representing approximately 160 million commercially insured medical lives—the authors probed which value tools payers were using and whether they were using more than one. The team then conducted in-depth interviews with payers who utilized 2 or more value tools in oncology management to gain insights on the perceived benefits and shortcomings of those tools, as well as to identify suggestions for improvement.

As reported in the paper, Schafer, Galante, and Shafrin found that nearly half of payers surveyed use multiple value tools in the drug management process. Interviews identified a number of areas where the tools could be revised to increase their utility to payers.

The article in JMCP, one of the most circulated peer-reviewed journals in managed care, represents an impressive collaboration between Precision for Value’s market research team combined with the significant scientific research understanding of Precision Health Economics.

Kudos to authors Schafer, Galante, and Shafrin!

Click here to read the complete article.

 

Precision Medicine Group is an integrated team of experts in fields from advanced lab sciences to translational informatics and regulatory affairs, payer insights to marketing communications. Together, we help our pharmaceutical and life-sciences clients conquer product development and commercialization challenges in a rapidly evolving environment.